Your browser doesn't support javascript.
loading
Advances in RIPK1 kinase inhibitors.
Chen, Lu; Zhang, Xiaoqin; Ou, Yaqing; Liu, Maoyu; Yu, Dongke; Song, Zhiheng; Niu, Lihong; Zhang, Lijuan; Shi, Jianyou.
Afiliação
  • Chen L; College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Zhang X; Department of Critical Care Medicine, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, Affiliated Hospital of University of Electronic Science and Tec1hnology of China, Chengdu, Sichuan, China.
  • Ou Y; Department of Pharmacy, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, Sichuan, China.
  • Liu M; Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Yu D; College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Song Z; College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Niu L; Department of Critical Care Medicine, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, Affiliated Hospital of University of Electronic Science and Tec1hnology of China, Chengdu, Sichuan, China.
  • Zhang L; Department of Pharmacy, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, Sichuan, China.
  • Shi J; Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Front Pharmacol ; 13: 976435, 2022.
Article em En | MEDLINE | ID: mdl-36249746

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China